Why couldn't they do both? Satisfy the FDA by altering the claims on the label, keeping Abloc on the market, and still pursuing a pharmaceutical drug. Not that far fetched. It is a bit puzzling that not much if any effort was made to keep Abloc on the market. Maybe there is more to it than the public was made aware of.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.